BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Ebola outbreak
    • Hantavirus
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Saturday, June 13, 2026
Home » Authors » Anette Breindl

Anette Breindl

Articles

ARTICLES

Cancer vaccine works, if you know where to look

Feb. 3, 2014
By Anette Breindl
Scientists reported recently that a therapeutic vaccine for precancerous cervical lesions induced strong immune responses. But those immune responses were only apparent when the team analyzed the cervical tissue itself, not when they used the standard approach of looking for activated immune cells in the blood.
Read More

Supplement-size doses of antioxidants hasten lung cancer progression

Jan. 30, 2014
By Anette Breindl
It is an article of faith among many health-conscious individuals that antioxidants are good for you – an article of faith that leads to a lot of vitamin sales. And in the typical “more is better” rationale that fuels many of those sales in the first place, most supplements provide many times the U.S. recommended daily allowance (RDA).
Read More

Cutting off sugars may enable broad-spectrum flu vaccine

Jan. 29, 2014
By Anette Breindl
Scientists from the Taiwanese Academia Sinica have reported that they have developed an influenza vaccine that was broadly protective in mice and ferrets by focusing not on the amino acid sequence of the vaccine antigen, but on how many sugars were attached to those amino acids.
Read More

Cutting off sugars may enable broad-spectrum flu vaccine

Jan. 29, 2014
By Anette Breindl
Scientists from the Taiwanese Academia Sinica reported that they have developed an influenza vaccine that was broadly protective in mice and ferrets by focusing not on the amino acid sequence of the vaccine antigen, but on how many sugars were attached to those amino acids.
Read More

Sex hormone controls blood stem cells

Jan. 27, 2014
By Anette Breindl
Sex organs are controlled by sex hormones, to nobody’s surprise – that’s their point. But now, researchers have shown that blood, too, is affected by sex hormones.
Read More

Studies show no smoking guns, or lots of them, in schizophrenia

Jan. 24, 2014
By Anette Breindl
Researchers have reported new insights into the genetic and neural mechanisms that underlie schizophrenia, and how the disease is related to other neurodevelopmental disorders at the cellular level.
Read More

Unnatural amino acids improve ADC precision

Jan. 22, 2014
By Anette Breindl
When they work, antibody-drug conjugates (ADCs) have it all: The precise targeting capability of an antibody allows clinicians to treat patients with drugs that are too toxic to be delivered systemically.
Read More

Multiple myeloma – adjusting our targeted therapy approach

Jan. 21, 2014
By Anette Breindl
Data published this week added to the understanding of just how complex multiple myeloma is, not just between patients but within a single patient.
Read More

Mutations in one cell type set off cancer in another

Jan. 16, 2014
By Anette Breindl
It’s an old story: Mutations lead to cancer. Except that in this case, mutations in one cell type lead to cancer in another.
Read More

Nanoparticles poison blood, for CTCs only

Jan. 13, 2014
By Anette Breindl
Scientists have engineered a nanoparticle that attaches to white blood cells in the blood stream and essentially uses them to hunt down circulating tumor cells (CTC).
Read More
View All Articles by Anette Breindl

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for June 12, 2026.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for June 9, 2026
  • Blood sample tubes after centrifuge

    Pre-disease plasma signature may help redefine lung cancer risk

    BioWorld
    Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...
  • Purple molecules

    Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis

    BioWorld
    Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
  • Neck exam

    Ethyreal launches to treat the underlying cause of Graves’, TED

    BioWorld
    Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing